$HIMS recently partnered with Klarna to offer payment plans for 6mo subscriptions of compounded GLP-1
Customers can finance the $1k 6mo sub vs paying the full amount upfront
๐จ BREAKING: TECH-DRIVEN HEDGE FUND BLKBRD BUYS 319K SHARES OF $HIMS
- 5% of portfolio
- Now #3 largest position for BLKBRD
- Other top holdings: $PLTR, $UNH, $HOOD, $NVO
@LABS is shaping up to be $HIMSโ AWS moment โ and the futureโs looking insanely bright.
๐๐
Weโre still $4 below JPMโs targetโฆ just imagine how undervalued this really is.
Morgan Stanley today raised its price target on Nvidia $NVDA to $220 up from $210 while maintaining its Overweight rating
Baird today initiated coverage on Microsoft $MSFT with a Outperform rating and a $600 price target
This morning we launched Labs, the easiest and most comprehensive way to get a real understanding of your health.
Labs offers an annual subscription that tests up to 120 of the most critical biomarkers in your body, for just a few hundred dollars. From genetic cardiovascular numbers to metabolic syndrome, these are the biomarkers at the cutting edge of innovation.
Data is helpful, but what comes next is what matters.
Immediately when your results are in, our platform in partnership with thousands of doctors, nurses and providers will provide you with a specific analysis and action plan. Nutrition, movement, supplements, and personalized medication options.
With over 1M square feet of pharmacy infrastructure, Hims & Hers doesnโt just test your health metrics, but unlocks your ability to actually improve them with access to precision treatments and care.
This is the first offering with Hims & Hers Iโm encouraging all of my family and friends to sign up for.
The power of knowledge and early action is unmatched, and for the people we love there is no greater gift.
https://t.co/BV22VqhFKT